Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seltorexant SAD in Healthy Japanese Males
NCT02555124Phase 1Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2015
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of seltorexant in Insomnia and major depressive disorder (MDD) (4 arms), sponsored by Janssen Pharmaceutical. Primary endpoints: Number of Participants With Adverse Events (AEs) and Number of Participants With Serious Adverse Events (SAEs). Started Sep 2015; status: completed.
02
Drugs
seltorexant
03
Conditions
Insomniamajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02555124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02555124.